| scholarly article | Q13442814 |
| P2093 | author name string | Jon C. Aster | |
| Stephen C. Blacklow | |||
| Warren S. Pear | |||
| P2860 | cites work | CIR, a corepressor linking the DNA binding factor CBF1 to the histone deacetylase complex | Q22008610 |
| NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the notch signaling pathway | Q24293498 | ||
| RBP-Jkappa/SHARP recruits CtIP/CtBP corepressors to silence Notch target genes | Q24294890 | ||
| Structural basis for cooperativity in recruitment of MAML coactivators to Notch transcription complexes | Q24307538 | ||
| Mutations in NOTCH1 cause aortic valve disease | Q24307999 | ||
| Mutations in the human Jagged1 gene are responsible for Alagille syndrome | Q24314702 | ||
| Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1 | Q24314766 | ||
| Mastermind recruits CycC:CDK8 to phosphorylate the Notch ICD and coordinate activation with turnover | Q24315524 | ||
| TAN-1, the human homolog of the Drosophila Notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms | Q24320364 | ||
| p300 and PCAF act cooperatively to mediate transcriptional activation from chromatin templates by notch intracellular domains in vitro | Q24537773 | ||
| p300 acts as a transcriptional coactivator for mammalian Notch-1 | Q24548267 | ||
| Nuclear localization of CBF1 is regulated by interactions with the SMRT corepressor complex | Q24550850 | ||
| A histone deacetylase corepressor complex regulates the Notch signal transduction pathway | Q24598533 | ||
| Direct inhibition of the NOTCH transcription factor complex | Q24634015 | ||
| Identification of a conserved negative regulatory sequence that influences the leukemogenic activity of NOTCH1 | Q24670708 | ||
| The Notch1 receptor is cleaved constitutively by a furin-like convertase | Q24671866 | ||
| Mastermind mediates chromatin-specific transcription and turnover of the Notch enhancer complex | Q24675233 | ||
| Structural basis for autoinhibition of Notch | Q27644319 | ||
| Structure of the Notch1-negative regulatory region: implications for normal activation and pathogenic signaling in T-ALL | Q27653136 | ||
| Effects of S1 Cleavage on the Structure, Surface Export, and Signaling Activity of Human Notch1 and Notch2 | Q27657133 | ||
| Therapeutic antibody targeting of individual Notch receptors | Q27660544 | ||
| Structural and mechanistic insights into cooperative assembly of dimeric Notch transcription complexes | Q27665343 | ||
| Transcription elongation factors repress transcription initiation from cryptic sites. | Q27931897 | ||
| Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes | Q28141631 | ||
| The Anti-apoptotic Effect of Notch-1 Requires p56 -dependent, Akt/PKB-mediated Signaling in T Cells | Q28212977 | ||
| Radiation-induced deletions in the 5' end region of Notch1 lead to the formation of truncated proteins and are involved in the development of mouse thymic lymphomas. | Q53378724 | ||
| The tumor suppressor gene hCDC4 is frequently mutated in human T-cell acute lymphoblastic leukemia with functional consequences for Notch signaling. | Q53545883 | ||
| NOTCH1 mutations in T-cell acute lymphoblastic leukemia: prognostic significance and implication in multifactorial leukemogenesis. | Q54601008 | ||
| Rag-dependent and Rag-independent mechanisms of Notch1 rearrangement in thymic lymphomas of Atm(-/-) and scid mice. | Q54789409 | ||
| Frequent provirus insertional mutagenesis of Notch1 in thymomas of MMTVD/myc transgenic mice suggests a collaboration of c-myc and Notch1 for oncogenesis | Q59285746 | ||
| Modulation of Notch signaling by antibodies specific for the extracellular negative regulatory region of NOTCH3 | Q80465114 | ||
| Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells | Q81974229 | ||
| Notch signaling in the immune system | Q82881379 | ||
| Genetic inactivation of Ikaros is a rare event in human T-ALL | Q84613405 | ||
| Identification of a T lineage-committed progenitor in adult blood. | Q40183324 | ||
| Targeting the NF-kappaB signaling pathway in Notch1-induced T-cell leukemia. | Q40195204 | ||
| Activating mutations in NOTCH1 in acute myeloid leukemia and lineage switch leukemias. | Q40226175 | ||
| Leukemia-associated mutations within the NOTCH1 heterodimerization domain fall into at least two distinct mechanistic classes | Q40273258 | ||
| Notch promotes survival of pre-T cells at the beta-selection checkpoint by regulating cellular metabolism | Q40390896 | ||
| Involvement of illegitimate V(D)J recombination or microhomology-mediated nonhomologous end-joining in the formation of intragenic deletions of the Notch1 gene in mouse thymic lymphomas. | Q40479977 | ||
| Jagged1-induced Notch signaling drives proliferation of multiple myeloma cells | Q40598947 | ||
| Functional Analysis of the TAN-1 Gene, a Human Homolog of Drosophila Notch | Q41506198 | ||
| Notch1 promotes survival of E2A-deficient T cell lymphomas through pre-T cell receptor-dependent and -independent mechanisms. | Q42256131 | ||
| Delta-like 4 is indispensable in thymic environment specific for T cell development | Q42277361 | ||
| FBXW7 and NOTCH1 mutations in childhood T cell acute lymphoblastic leukaemia and T cell non-Hodgkin lymphoma | Q43721199 | ||
| Mouse Fbw7/Sel-10/Cdc4 is required for notch degradation during vascular development. | Q44691496 | ||
| Deficient T cell fate specification in mice with an induced inactivation of Notch1. | Q45345200 | ||
| Requirement for Notch1 signals at sequential early stages of intrathymic T cell development | Q45345203 | ||
| Notch signaling controls the generation and differentiation of early T lineage progenitors | Q45345206 | ||
| Suppressor of hairless directly activates transcription of enhancer of split complex genes in response to Notch receptor activity | Q45950823 | ||
| The outcome of molecular-cytogenetic subgroups in pediatric T-cell acute lymphoblastic leukemia: a retrospective study of patients treated according to DCOG or COALL protocols. | Q50926294 | ||
| Notch1 expression in early lymphopoiesis influences B versus T lineage determination. | Q51085324 | ||
| Activation and transposition of endogenous retroviral elements in hypomethylation induced tumors in mice. | Q51579160 | ||
| Prognostic significance of molecular-cytogenetic abnormalities in pediatric T-ALL is not explained by immunophenotypic differences. | Q51975366 | ||
| Regulation of marginal zone B cell development by MINT, a suppressor of Notch/RBP-J signaling pathway | Q52603545 | ||
| Activating NOTCH1 mutations predict favorable early treatment response and long-term outcome in childhood precursor T-cell lymphoblastic leukemia. | Q52933515 | ||
| Activating Notch1 mutations are an early event in T-cell malignancy of Ikaros point mutant Plastic/+ mice. | Q53343606 | ||
| NOTCH is a key regulator of human T-cell acute leukemia initiating cell activity | Q39921283 | ||
| Aberrant expression of Notch1 interferes with the B-lymphoid phenotype of neoplastic B cells in classical Hodgkin lymphoma. | Q39986630 | ||
| Mutational and energetic studies of Notch 1 transcription complexes | Q40031628 | ||
| Notch signals positively regulate activity of the mTOR pathway in T-cell acute lymphoblastic leukemia | Q40158237 | ||
| Signalling downstream of activated mammalian Notch | Q28289832 | ||
| Regulation of CD23 expression by Notch2 in B-cell chronic lymphocytic leukemia | Q28300257 | ||
| Rbm15 modulates Notch-induced transcriptional activation and affects myeloid differentiation | Q28591012 | ||
| Calcium depletion dissociates and activates heterodimeric notch receptors | Q28609673 | ||
| Notch2 is involved in the overexpression of CD23 in B-cell chronic lymphocytic leukemia | Q28646247 | ||
| The canonical Notch signaling pathway: unfolding the activation mechanism | Q29547725 | ||
| Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia | Q29614269 | ||
| The OTT-MAL fusion oncogene activates RBPJ-mediated transcription and induces acute megakaryoblastic leukemia in a knockin mouse model | Q33383707 | ||
| NOTCH1/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) study | Q33395926 | ||
| Hes1 potentiates T cell lymphomagenesis by up-regulating a subset of notch target genes | Q33494549 | ||
| Characterization of Notch1 antibodies that inhibit signaling of both normal and mutated Notch1 receptors | Q33531734 | ||
| Histone demethylase KDM5A is an integral part of the core Notch-RBP-J repressor complex | Q33737810 | ||
| Mutant Ikzf1, KrasG12D, and Notch1 cooperate in T lineage leukemogenesis and modulate responses to targeted agents | Q33739961 | ||
| The mastermind-like 1 (MAML1) co-activator regulates constitutive NF-kappaB signaling and cell survival | Q33825084 | ||
| The in vivo pattern of binding of RAG1 and RAG2 to antigen receptor loci. | Q33889784 | ||
| Two distinct Notch1 mutant alleles are involved in the induction of T-cell leukemia in c-myc transgenic mice | Q33963617 | ||
| Combined expression of pTalpha and Notch3 in T cell leukemia identifies the requirement of preTCR for leukemogenesis | Q34020330 | ||
| γ-secretase-dependent cleavage initiates notch signaling from the plasma membrane | Q34057805 | ||
| Notch2 is preferentially expressed in mature B cells and indispensable for marginal zone B lineage development | Q34197865 | ||
| Notch activation is an early and critical event during T-Cell leukemogenesis in Ikaros-deficient mice | Q34233443 | ||
| Common sites of retroviral integration in mouse hematopoietic tumors identified by high-throughput, single nucleotide polymorphism-based mapping and bacterial artificial chromosome hybridization | Q34465679 | ||
| Notch1 mutations are important for leukemic transformation in murine models of precursor-T leukemia/lymphoma | Q34481661 | ||
| Deletion-based mechanisms of Notch1 activation in T-ALL: key roles for RAG recombinase and a conserved internal translational start site in Notch1. | Q34541666 | ||
| NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth | Q34582832 | ||
| Predominant interaction of both Ikaros and Helios with the NuRD complex in immature thymocytes | Q34660281 | ||
| c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma | Q34958884 | ||
| Oncogenic activation of the Notch1 gene by deletion of its promoter in Ikaros-deficient T-ALL. | Q34999834 | ||
| Metalloprotease ADAM10 is required for Notch1 site 2 cleavage. | Q35000965 | ||
| Constitutive activation of NF-kappaB and T-cell leukemia/lymphoma in Notch3 transgenic mice | Q35114942 | ||
| Notch1 contributes to mouse T-cell leukemia by directly inducing the expression of c-myc | Q35131413 | ||
| Quantitative dissection of the Notch:CSL interaction: insights into the Notch-mediated transcriptional switch. | Q35749862 | ||
| Cooperative assembly of higher-order Notch complexes functions as a switch to induce transcription | Q35844655 | ||
| Activating Notch1 mutations in mouse models of T-ALL. | Q35849320 | ||
| Regulation of lymphoid development, differentiation, and function by the Notch pathway. | Q36072476 | ||
| Distinct gene expression profiles of acute myeloid/T-lymphoid leukemia with silenced CEBPA and mutations in NOTCH1. | Q36141686 | ||
| Interleukin-7 in T-cell acute lymphoblastic leukemia: an extrinsic factor supporting leukemogenesis? | Q36194601 | ||
| FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors | Q36229551 | ||
| The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia | Q36229601 | ||
| Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles | Q36366728 | ||
| Separation of Notch1 promoted lineage commitment and expansion/transformation in developing T cells | Q36369337 | ||
| Loss of intestinal crypt progenitor cells owing to inactivation of both Notch1 and Notch2 is accompanied by derepression of CDK inhibitors p27Kip1 and p57Kip2. | Q36528951 | ||
| NOTCH1 extracellular juxtamembrane expansion mutations in T-ALL. | Q36787487 | ||
| Leukemia-associated NOTCH1 alleles are weak tumor initiators but accelerate K-ras-initiated leukemia | Q36800426 | ||
| K-RasG12D-induced T-cell lymphoblastic lymphoma/leukemias harbor Notch1 mutations and are sensitive to gamma-secretase inhibitors | Q36941105 | ||
| Oncogenesis of T-ALL and nonmalignant consequences of overexpressing intracellular NOTCH1 | Q36979929 | ||
| Ikaros represses the transcriptional response to Notch signaling in T-cell development | Q36994950 | ||
| Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia | Q37009642 | ||
| Notch signaling in leukemia | Q37014817 | ||
| Defective cardiovascular development and elevated cyclin E and Notch proteins in mice lacking the Fbw7 F-box protein | Q37073031 | ||
| CCR7 signalling as an essential regulator of CNS infiltration in T-cell leukaemia | Q37113435 | ||
| Gamma-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia | Q37215995 | ||
| Targeting the Notch1 and mTOR pathways in a mouse T-ALL model | Q37234630 | ||
| Pre-TCR signaling inactivates Notch1 transcription by antagonizing E2A. | Q37272317 | ||
| Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers | Q37272977 | ||
| CSL-MAML-dependent Notch1 signaling controls T lineage-specific IL-7R{alpha} gene expression in early human thymopoiesis and leukemia | Q37273302 | ||
| The impact of NOTCH1, FBW7 and PTEN mutations on prognosis and downstream signaling in pediatric T-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group | Q37303838 | ||
| Prognostic implications of NOTCH1 and FBXW7 mutations in adults with T-cell acute lymphoblastic leukemia treated on the MRC UKALLXII/ECOG E2993 protocol | Q37347511 | ||
| Notch-induced E2A ubiquitination and degradation are controlled by MAP kinase activities | Q37368153 | ||
| Angiogenesis: a team effort coordinated by notch. | Q37393190 | ||
| Ikaros regulates Notch target gene expression in developing thymocytes | Q37424241 | ||
| Notch signaling specifies megakaryocyte development from hematopoietic stem cells. | Q37673550 | ||
| Notch3 and the Notch3-upregulated RNA-binding protein HuD regulate Ikaros alternative splicing | Q38304159 | ||
| Induction of apoptosis by proteasome inhibitors in B-CLL cells is associated with downregulation of CD23 and inactivation of Notch2. | Q38333825 | ||
| Perturbation of Ikaros isoform selection by MLV integration is a cooperative event in Notch(IC)-induced T cell leukemogenesis | Q38352939 | ||
| Gain-of-function mutations and copy number increases of Notch2 in diffuse large B-cell lymphoma | Q38354055 | ||
| BCL6 canalizes Notch-dependent transcription, excluding Mastermind-like1 from selected target genes during left-right patterning | Q39684544 | ||
| Ikaros directly represses the notch target gene Hes1 in a leukemia T cell line: implications for CD4 regulation | Q39782908 | ||
| Selective use of ADAM10 and ADAM17 in activation of Notch1 signaling | Q39808768 | ||
| Transduction of Notch2 in feline leukemia virus-induced thymic lymphoma | Q39876976 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | leukemia | Q29496 |
| P304 | page(s) | 262-273 | |
| P577 | publication date | 2010-10-21 | |
| P1433 | published in | Journal of Pathology | Q400296 |
| P1476 | title | Notch signalling in T-cell lymphoblastic leukaemia/lymphoma and other haematological malignancies | |
| Notch signalling in T‐cell lymphoblastic leukaemia/lymphoma and other haematological malignancies | |||
| P478 | volume | 223 |
| Q43170125 | A Phase 1 study of the novel gamma-secretase inhibitor PF-03084014 in patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma. |
| Q35914892 | A complex Polycomb issue: the two faces of EZH2 in cancer |
| Q39542558 | A novel TRB@/NOTCH1 fusion gene in T-cell lymphoblastic lymphoma with t(7;9)(q34;q34). |
| Q39232343 | A role for Jag2 in promoting uveal melanoma dissemination and growth |
| Q36837426 | Activated Notch counteracts Ikaros tumor suppression in mouse and human T-cell acute lymphoblastic leukemia |
| Q90482750 | Advances in targeted therapy for malignant lymphoma |
| Q36015013 | An activating intragenic deletion in NOTCH1 in human T-ALL. |
| Q36043664 | Analysis of Rho GTPase expression in T-ALL identifies RhoU as a target for Notch involved in T-ALL cell migration |
| Q27851655 | Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation |
| Q37810056 | Cancer biology and genomics: translating discoveries, transforming pathology |
| Q60111451 | Cancer: The flipside of Notch |
| Q52650208 | Cell competition is a tumour suppressor mechanism in the thymus. |
| Q36318700 | Characterization of CSL (CBF-1, Su(H), Lag-1) mutants reveals differences in signaling mediated by Notch1 and Notch2. |
| Q58611094 | Co-expression analysis reveals mechanisms underlying the varied roles of NOTCH1 in non-small cell lung cancer |
| Q39168183 | Collaborating Pathways that Functionally Amplify NOTCH1 Signals in T-Cell Acute Lymphoblastic Leukemia |
| Q28274701 | Comprehensive genomic characterization of squamous cell lung cancers |
| Q37911375 | Critical roles of NOTCH1 in acute T-cell lymphoblastic leukemia |
| Q36192366 | DDX5 is a positive regulator of oncogenic NOTCH1 signaling in T cell acute lymphoblastic leukemia |
| Q38233767 | Developmental gene networks: a triathlon on the course to T cell identity |
| Q30525783 | Direct observation of proteolytic cleavage at the S2 site upon forced unfolding of the Notch negative regulatory region |
| Q92186299 | Disruption of NOTCH signaling by a small molecule inhibitor of the transcription factor RBPJ |
| Q38151514 | Dll4-Notch signaling in regulation of tumor angiogenesis |
| Q35004941 | Dnmt3a loss predisposes murine hematopoietic stem cells to malignant transformation. |
| Q26745755 | Does Notch play a tumor suppressor role across diverse squamous cell carcinomas? |
| Q28283633 | Dosage-dependent tumor suppression by histone deacetylases 1 and 2 through regulation of c-Myc collaborating genes and p53 function |
| Q34700307 | Ectopic expression of homeobox gene NKX2-1 in diffuse large B-cell lymphoma is mediated by aberrant chromatin modifications |
| Q53158331 | Elevated TRIB2 with NOTCH1 activation in paediatric/adult T-ALL. |
| Q57136305 | Emerging EZH2 Inhibitors and Their Application in Lymphoma |
| Q34186057 | Enhanced Notch activation is advantageous but not essential for T cell lymphomagenesis in Id1 transgenic mice |
| Q35742745 | Genetic inactivation of the polycomb repressive complex 2 in T cell acute lymphoblastic leukemia |
| Q35202653 | Genome-wide analysis reveals conserved and divergent features of Notch1/RBPJ binding in human and murine T-lymphoblastic leukemia cells |
| Q38881657 | Human NOTCH2 Is Resistant to Ligand-independent Activation by Metalloprotease Adam17. |
| Q34120726 | Impact of complex NOTCH1 mutations on survival in paediatric T-cell leukaemia. |
| Q34475754 | Initial testing (stage 1) of the notch inhibitor PF-03084014, by the pediatric preclinical testing program |
| Q35836383 | Insights into Autoregulation of Notch3 from Structural and Functional Studies of Its Negative Regulatory Region |
| Q37213634 | Integrative genetic, epigenetic and pathological analysis of paraganglioma reveals complex dysregulation of NOTCH signaling. |
| Q38959859 | Kaposi's sarcoma-associated herpesvirus Rta tetramers make high-affinity interactions with repetitive DNA elements in the Mta promoter to stimulate DNA binding of RBP-Jk/CSL. |
| Q34446281 | Long-range enhancer activity determines Myc sensitivity to Notch inhibitors in T cell leukemia |
| Q34421363 | Loss of oncogenic Notch1 with resistance to a PI3K inhibitor in T-cell leukaemia |
| Q35471421 | Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma |
| Q47297141 | Mbd3/NuRD controls lymphoid cell fate and inhibits tumorigenesis by repressing a B cell transcriptional program. |
| Q36240624 | Mesenchymal deficiency of Notch1 attenuates bleomycin-induced pulmonary fibrosis. |
| Q36602853 | MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid Malignancies |
| Q38771110 | Molecular genetics of childhood, adolescent and young adult non-Hodgkin lymphoma. |
| Q38065304 | Molecular genetics of high-risk chronic lymphocytic leukemia |
| Q64085662 | Molecular pathogenic pathways in extranodal NK/T cell lymphoma |
| Q37728495 | Multifactorial ERβ and NOTCH1 control of squamous differentiation and cancer. |
| Q30661393 | Mutational analysis of the Notch2 negative regulatory region identifies key structural elements for mechanical stability |
| Q35945755 | Mutations increased overexpression of Notch1 in T-cell acute lymphoblastic leukemia |
| Q27851685 | Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia |
| Q55668973 | NOTCH1 Aberrations in Chronic Lymphocytic Leukemia. |
| Q53259951 | NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome. |
| Q35669190 | NOTCH1 mutations in CLL associated with trisomy 12. |
| Q64971129 | NOTCH1 regulates the viability of cholangiocarcinoma cells via 14-3-3 theta. |
| Q34055685 | Notch ankyrin repeat domain variation influences leukemogenesis and Myc transactivation. |
| Q51369795 | Notch pathway plays a novel and critical role in regulating responses of T and antigen-presenting cells in aGVHD. |
| Q35838949 | Notch signal suppresses Toll-like receptor-triggered inflammatory responses in macrophages by inhibiting extracellular signal-regulated kinase 1/2-mediated nuclear factor κB activation |
| Q53087981 | Notch signaling in peripheral T-cell lymphoma: revelations from immunohistochemistry. |
| Q34898535 | Notch signaling in the malignant bone marrow microenvironment: implications for a niche-based model of oncogenesis |
| Q36288207 | Notch signaling promotes growth and invasion in uveal melanoma |
| Q36779521 | Notch transcriptional control of vascular smooth muscle regulatory gene expression and function |
| Q36874225 | Notch1 signaling is involved in regulating Foxp3 expression in T-ALL. |
| Q28477072 | Notch3 is dispensable for thymocyte β-selection and Notch1-induced T cell leukemogenesis |
| Q37101418 | Notching up MYC gives a LIC. |
| Q37719992 | Overexpression of SLC25A38 protein on acute lymphoblastic leukemia cells |
| Q101239446 | Phase 1 study to evaluate Crenigacestat (LY3039478) in combination with dexamethasone in patients with T-cell acute lymphoblastic leukemia and lymphoma |
| Q34335672 | RBPJ is a novel target for rhabdomyosarcoma therapy |
| Q35190609 | Redundancy and specificity of the metalloprotease system mediating oncogenic NOTCH1 activation in T-ALL. |
| Q38174045 | Role of Notch signalling pathway in cancer and its association with DNA methylation |
| Q60955796 | Secondary Thymoma among Adult Treated For Acute Lymphoblastic Lymphoma/Leukemia: Report of a Case and Review of the Literature |
| Q98156928 | T-cell lymphoblastic lymphoma and leukemia: different diseases from a common premalignant progenitor? |
| Q35676920 | Targeting Homologous Recombination in Notch-Driven C. elegans Stem Cell and Human Tumors |
| Q36347511 | Targeting Transcription Factors in Cancer |
| Q53254337 | The Expression of Notch 1 and Notch 3 in Gallbladder Cancer and Their Clinicopathological Significance. |
| Q58063547 | The NOTCH1/CD44 axis drives pathogenesis in a T cell acute lymphoblastic leukemia model |
| Q43004414 | The Notch signaling pathway in hematopoiesis and hematologic malignancies |
| Q38222770 | The challenge of targeting notch in hematologic malignancies |
| Q36513656 | The differential expression pattern of the BMI-1, SALL4 and ABCA3 genes in myeloid leukemia |
| Q39342547 | The involvement of Notch signaling in melanoma vasculogenic mimicry |
| Q38664822 | The role of next-generation sequencing in understanding the genomic basis of diffuse large B cell lymphoma and advancing targeted therapies |
| Q38203927 | The role of notch signaling in bone marrow niche. |
| Q36426587 | The spectrum of genetic defects in chronic lymphocytic leukemia |
| Q91474255 | Therapeutic targeting of the E3 ubiquitin ligase SKP2 in T-ALL |
| Q35202831 | Transcription factor RBPJ/CSL: a genome-wide look at transcriptional regulation |
| Q61814317 | Transcriptomic Abnormalities in Epstein Barr Virus Associated T/NK Lymphoproliferative Disorders |
| Q42537461 | Trisomy 12 CLLs progress through NOTCH1 mutations |
| Q37995197 | Vav1 in hematologic neoplasms, a mini review. |
| Q34293927 | Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma. |
Search more.